Kronenberg F, Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann Intern Med 2002; 137: 805–813.
2. Possible health impact of phytoestrogens and xenoestrogens in food. APMIS 2001; 109: 161–184.
Lewiecki EM. Phytoestrogens and their role in the management of postmenopausal osteoporosis. South Med Journal 2009; 102(1): 111–112.
Messina M. The safety and benefits of soybean isoflavones. A natural alternative to conventional hormone therapy?Menopause 2007; 14: 958.
Hoope RL, Ryder JJ, Kurzer MS, et al. Effects of soy protein and isoflavones on circulating hormone concentrations in pre- and post-menopausal women: a systematic review and meta-analysis. Hum Reprod Update 2009; 1(1): 1–18.
Gallo D, Zannoni GF, Apollonio P, et al. Characterization of the pharmacologic profile of a standardized soy extract in he ovariectomized rat model of menopause: effects on bone, uterus, and lipid profile. Menopause 2005; 12: 589–600.
Hwang CS, Kwak HS, Lim HJ, et al. Isoflavone metabolites and their in vitro dual functions: they can act as an estrogenic agonist or antagonist depending on the estrogen concentration. J Steroid Biochem Mol Biol 2006; 101: 246–253.
Rice S, Mason HD, Whitehead SA. Phytoestrogens and their low dose combinations inhibit mRNA expression and activity of aromatase in human granulosa-luteal cells. J Steroid Biochem Mol Biol 2006; 101: 216–225.
Lacey M, Bohday J, Fonseka SM, et al. Dose–response effects of phytoestrogens on the activity and expression of 3beta-hydroxysteroid dehydrogenase and aromatase in human granulosa-luteal cells. J Steroid Biochem Mol Biol 2005; 96: 279–286.
Adlercreutz H, Mazur W. Phyto-oestrogens and Western diseases. Ann Me
Howes LG, Howes JB, Knight DC. Isoflavone therapy for menopausal flushes: a systematic review and meta-analysis. Maturitas 2006; 55: 211.
Messina M, et al. Isoflavone supplements containing predominantly genisteinreduce hot flash symptoms: a critical review of published studies. Menopause 2006; 13: 831–839.
Marini H, Minutoli L, Polito F, et al. Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a randomized trial. Ann Intern Med 2007; 146: 839–847.
Ma DF, Qin LQ, Wang PY, et al. Soy isoflavone intake increases bone mineral density in the spine of menopausal women: meta-analysis of randomized controlled trials. Clin Nutr 2008; 27: 57–64.
Balk E, Chung M, Chew P et al. Effects of soy on health outcomes. Evid Rep Technol Assess 2005; 126: 1–8.
Nelson HD, Vesco KK, Haney E, et al. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA 2006; 295: 2057–2071.
Sacks FM, Lichtenstein AH, Van Horn L, Harris W, Kris-Etherton PM, Winston MC. Soy protein, isoflavones, and cardiovascular health: a summary of a statement for professionals from the American heart association nutrition committee.Arterioscler Thromb Vasc Biol 2006; 26: 1689–1692.
Erdman JW Jr, Badger TM, Lampe JW, et al. Not all soy products are created equal: caution needed in interpretation of research results. J Nutr 2004; 134: 1223S–1233S.
Coon JT, Pittler MH , Ernst E. Trifolium pratense isoflavones in the treatment of menopausal hot flushes: a systematic review and meta-analysis. Phytomedicine 2007; 14: 153–159.
Whelan AM, Jurgens TM, Bowles SK. Natural health products in the prevention and treatment of osteoporosis: systematic review of randomized controlled trials. Ann Pharmacother 2006; 40: 836–849.
Morabito N, Crisafulli A, Vergara C, et al. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. J Bone Miner Res 2002; 17:1904–1912.
Tempfer C, Froese G, Heinze G, et al. Side effects of phytoestrogens: a meta-analysis of randomized trials. Am J Med 2009; 122(10): 939–946.
Khaodhiar L, Ricciotti H A, Li L, et al. Daidzein-rich isoflavone aglycones are potentially effective in reducing hot flashes in menopausal women. Menopause 2008; 15: 125–132.
González S, Jayagopal V, Kilpatrick ES, et al. Effects of isoflavone dietary supplementation on cardiovascular risk factors in type 2 diabetes. Diab Care 2007; 30: 1871–1873.
Ho SC, Chan AS, Ho Y P, et al. Effects of soy isoflavone supplementation on cognitive function in Chinese postmenopausal women: a double-blind, randomized, controlled trial. Menopause 2007; 14(3 Pt 1): 489–499.
Nahas EA, Nahas-Neto J, Orsatti FL, et al. Efficacy and safety of a soy isoflavone extract in postmenopausal women: a randomized, double-blind, and placebo-controlled study. Maturitas 2007; 58: 249–258.
Zhang G, Qin L, Shi Y . Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial. J Bone Miner Res 2007; 22: 1072–1089.
Ferrari A. Soy extract phytoestrogens with high dose of isoflavones for menopausal symptoms. J Obstet Gynaecol Res 2009; 35(6): 1083–1090.
Milewicz A, Jędrzejuk D. Co możemy zaoferować jako lekarze rodzinni pacjentce po operacji raka gruczołu piersiowego w aspekcie następstw niedoboru estrogenów? Family Med Prim Care Rev 2005; 7(3): 765–768.
Czekirda M, Ślusarska B, Adamska-Kuźmicka I, i wsp. Satysfakcja z życia kobiet w okresie przekwitania. Fam Med Prim Care Rev 2007; 9(2): 220–228.
Cederroth CR, Nef S. Soy, phytoestrogens and metabolizm. Mol Cell Endocrinol 2009; 304(1–2): 30–42.
. Kelly GE, Nelson C, Waring MA, et al. Metabolites of dietary (soya) isoflavones in human urine. Clin Chim Acta 1993;